Skip to content

Drug interactions

Brentuximab + Sotorasib

Severity: Moderate

Brentuximab and Sotorasib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sotorasib is a P-gp inhibitor that raises exposure of P-gp substrates, such as digoxin. MMAE from brentuximab vedotin is a P-gp substrate, so its exposure could increase and lead to more neutropenia and neuropathy. The legacy direction of a decrease is not mechanistically supported.

What this interaction means in plain words

Brentuximab and Sotorasib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Brentuximab belongs to Oncology; Sotorasib belongs to Oncology.

Evidence level: Low

Why it happens

P-gp inhibition by sotorasib may increase MMAE exposure.

What to do

Monitor blood counts and for neuropathy. Adjust or hold brentuximab if toxicity occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Brentuximab and Sotorasib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Brentuximab with Sotorasib?

MediHelp rates the interaction as moderate. Brentuximab and Sotorasib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sotorasib is a P-gp inhibitor that raises exposure of P-gp substrates, such as digoxin. MMAE from brentuximab vedotin is a P-gp substrate, so its exposure could increase and lead to more neutropenia and neuropathy. The legacy direction of a decrease is not mechanistically supported.

How serious is the interaction between Brentuximab and Sotorasib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and for neuropathy. Adjust or hold brentuximab if toxicity occurs.

What other medicines interact with Brentuximab?

MediHelp also lists interactions of Brentuximab with, for example, Bleomycin, Dengue vaccine, Etrasimod. The full list is on the Brentuximab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in